Once daily insulin glargine may induce loss of basal insulin action in some patients with type 1 diabetes receiving basal bolus regimens: The need for twice daily glargine?

被引：0
|
作者：
Idampitiya, C
Ward, K
Curtis, C
Fernando, DJS
Idris, I
Thomson, G
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A493 / A493
页数：1
相关论文
共 50 条
  • [1] Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
    Chantal Mathieu
    S. John Weisnagel
    Peter Stella
    Jacques Bruhwyler
    Kathy Alexandre
    Diabetes Therapy, 2020, 11 : 495 - 507
  • [2] Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens
    Rosenstock, J
    Park, G
    Zimmerman, J
    DIABETES CARE, 2000, 23 (08) : 1137 - 1142
  • [3] Efficacy of once daily insulin glargine as basal insulin replacement in insulin-deficient diabetes
    Meneghini, Luigi F.
    Wick, Allison K.
    Sparrow-Bodenmiller, Jane
    Avila, Ana M.
    DIABETES, 2006, 55 : A125 - A125
  • [4] Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study
    Mathieu, Chantal
    Weisnagel, S. John
    Stella, Peter
    Bruhwyler, Jacques
    Alexandre, Kathy
    DIABETES THERAPY, 2020, 11 (02) : 495 - 507
  • [5] Changing from once- or twice-daily basal insulin to once-daily insulin glargine using two titration regimens in Type 1 diabetes: results from the AT.LANTUS trial
    Raz, I
    Storms, F
    Rodriguez, J
    Bianchi-Biscay, M
    Davies, M
    Gomis, R
    DIABETOLOGIA, 2004, 47 : A306 - A306
  • [6] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Cleall, S.
    Rodriguez, A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 963 - 970
  • [7] Cost-utility analysis of once-weekly insulin icodec and once-daily insulin glargine in patients with type 2 diabetes receiving basal-bolus insulin therapy in China
    Dai, Nan
    Su, Xiaorong
    Wang, Yong
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 377 - 386
  • [8] Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Zhou, Z.
    Cleall, S.
    Rodriguez, A.
    DIABETOLOGIA, 2013, 56 : S412 - S412
  • [9] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial
    Douglas Eugenio Barbieri
    Ran Duan
    Jorge Gross
    Bruno Linetzky
    Janaina Martins De Lana
    Arturo Rojas
    Georgina Sposetti
    Oded Stempa
    Angel Rodriguez
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [10] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial
    Rojas, Arturo
    Sposetti, Georgina
    Gross, Jorge L.
    Barbieri, Douglas Eugenio
    Duan, Ran
    Linetzky, Bruno
    De Lana, Janaina Martins
    Stempa, Oded
    Rodriguez, Angel
    DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
12345